-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

626.P1.42 626. Aggressive Lymphomas: Clinical and Epidemiological: Poster I

Symposia: Aggressive Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Ming Jiang1*, Liqun Zou2*, Lijie Liang3*, Yingze Liu4*, Na Li5* and You Feng5*

1Department of Head & Neck Oncology, Cancer Center, West China Hospital of Sichuan University, Chengdu, China
2West China Hospital of Sichuan University, Chengdu, China
3Chongqing University Cancer Hospital, chongqing, China
4Nanjing Geneseeq Technology Inc., Nanjing, Jiangsu, China, nanjing, China
5West China Fourth Hospital of Sichuan University, Chengdu, China

Chathuri Abeyakoon, MBBS1, Sita D. Bhella, MD1, Katrina Hueniken2*, Rachel Aitken1*, Carmel Waldron3*, Anca Prica, MD1, Vishal Kukreti, MD, MSc4, Robert Kridel, MD, PhD1, Abi Vijenthira, MD, MS1, Christine I Chen, MHPE, MD5, Chloe Yang, MD6*, Richard Tsang, MD7*, David Hodgson, MD7*, Danielle Rodin, MD, MPH7*, Nauman Malik7*, Woodrow Wells7*, Michael Crump, MD1* and John Kuruvilla, MD, FRCPC1

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
2Department of Biostatistics, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
3Department of Hematology, St James' Hospital, Dublin 8, IRL
4Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
6Princess Margaret Cancer Centre, Toronto, ON, Canada
7Division of Radiation Oncology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada

Nicolò Rampi, MD1*, Alessandro Bosi, MD2*, Michele Merli, MD3*, Maria Goldaniga, MD4*, Stefano Ferrero, MD5,6*, Stefano Fiori, MD5*, Giorgio alberto Croci, MD7*, Francesco Blasi, MD8,9*, Valeria Rossetti, MD9*, Letizia Morlacchi, MD8,9*, Mario Nosotti, MD8,10*, Lorenzo Rosso, MD8,10*, Pietro Lampertico, MD8,11*, Francesca Donato, MD11*, Clara Dibenedetto, MD11*, Lucio Caccamo, MD12*, Barbara Antonelli, MD12*, Maria Campise, MD13*, Mariano Ferraresso, MD14*, Evaldo Favi, MD14,15*, Giorgia Saporiti, MD4*, Fabio Serpenti, MD4*, Kordelia Barbullushi, MD4*, Bruno Fattizzo, MD1,16, Francesca Gaia Rossi, MD17* and Francesco Passamonti, MD18,19*

1Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
2Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy, Milan, Italy
3Hematology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy
4SC Ematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy
5Pathology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
6Department of Biomedical, Surgical and Dental Sciences, University of Milan, Milan, Italy
7Pathology Unit, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milano, Italy
8Department of Pathophysiology and Transplantation University of Milan, Milan, Italy
9Respiratory Unit and Cystic Fibrosis Center Fondazione IRCCS OCR Granda Ospedale Maggiore Policlinico, Milan, Italy
10Thoracic Surgery and Lung Transplantation Unit Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
11Gastroenterology and Hepatology Unit,Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Milan, Italy
12General Surgery and Liver Transplantation Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
13SC Nephrology, Dialysis and Kidney Transplantation Fondazione IRCCS Ospedale Maggiore Policlinico, Milan, Italy
14General Surgery and Kidney Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
15Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy
16Department of Oncology and Hemato-Oncology, University of Milan, Milano, Italy
17Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
18Università degli Studi di Milano, Milano, Italy
19Dipartimento di Oncologia ed Ematologia, Università degli Studi di Milano, Policlinico di Milano, Ospedale Maggiore, Fondazione I.R.C.C.S. Ca Granda, Milano, Italy

Prokop Vodicka1*, Katerina Benesova, MD, PhD1*, Andrea Janikova, MD, PhD2*, David Belada, MD, PhD3, Andrea Hruskova, MD4*, Heidi Mocikova, MD5*, Juraj Duras, MD, PhD6*, Katerina Steinerova, MD, PhD7*, Alice Sykorova, MD, PhD8*, Michal Masar, MD1*, Jitka Dlouha, DiS1,9*, Petra Blahovcova, Mgr1,10* and Marek Trneny, MD, CSc11

1First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
2Department of Hematology and Oncology, Faculty of Medicine Masaryk University and University Hospital, Brno, Czech Republic
34th Department of Internal Medicine – Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic
4Department of Haemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
5Department of Internal Medicine – Hematology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, AE
6Department of Hematology, Medical Faculty of the Ostrava University and University Hospital, Ostrava, Czech Republic
7Department of Haematology and Oncology, Faculty of Medicine, Charles University and University Hospital, Pilsen, Czech Republic
84th Department of Internal Medicine – Hematology, Faculty of Medicine, Charles University and University Hospital, Hradec Kralove, Czech Republic
9Datacentre, Czech Lymphoma Study Group, Prague, Czech Republic
10Czech Lymphoma Study Group, Prague, Czech Republic
11First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic

Cristina García Herce1*, Anna Martín Carrizosa, MD1*, Lorenzo Carita2*, Víctor Navarro Garces2*, Belén Navarro3*, Eva Donato4*, Blanca Sánchez González5*, Clara González Santillana, MD6*, Ana Jiménez Ubieto7*, Luis Antonio López Gómez, MD8*, Angel Serna, MD1*, Ángeles Arnaldos López, MD9*, Ana Garcia Noblejas, MD, PhD10*, Concepción Nicolás11*, Rosalia Alonso Trillo, MD12*, Estefania Cerezo Velasco, MD13*, Daniel García Belmonte14*, Beatriz De La Cruz15*, Ana Alarcon Tomas, MD16*, Francesc Bosch, MD, PhD1 and Pau Abrisqueta, MD PhD1

1Hematology Department, Hospital Universitario Vall d’Hebron, Barcelona, Spain
2Statistic Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
3Hematology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
4Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain
5Hematology Department, Hospital del Mar, Barcelona, Spain
6Hematology Department, Hospital Universitario de Fuenlabrada, Madrid, Spain
7Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
8Hematology Department, Hospital Universitario Royo Villanova, Zaragoza, Spain
9Hematology Department, Hospital Universitario de Tarragona Juan XXIII, Tarragona, Spain
10Hematology Department, Hospital Universitario La Princesa, Madrid, Spain
11Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
12Hematology Department, Hospital Universitario de Getafe, Madrid, Spain
13Hematology Department, Consorcio Sanitario de Terrassa, Terrassa, Spain
14Hematology Department, Hospital Universitario la Zarzuela, Madrid, Spain
15Hematology Department, Hospital Universitario La Paz, Madrid, Spain
16Hematology Department, Hospital Universitario Puerta de Hierro, Majadahonda-Madrid, Spain

Nikita Dave1, Veronica Carvajal, BS2*, Jordan Carter, MD3*, Donald Edward Tsai, MD4*, Stephen J. Schuster, MD3, James Gerson, MD5*, Stefan K. Barta, MD, MS6*, Jakub Svoboda, MD7, Elise A. Chong, MD8, Daniel J. Landsburg, MD9 and Sunita D. Nasta, MD9

1Division of Hematology-Oncology, The University of Pennsylvania School of Medicine, Philadelphia, PA
2Hospital of the University of Pennsylvania, Philadelphia
3School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
4Hospital of the Univ. of Penn., Springfield, PA
5Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
6Perelman Center for Advanced Medicine - University of Pennsylvania, Philadelphia, PA
7Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
8Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
9Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA

Victor S. Lin, BBiomed, MD, MPH, MMed1*, Sean Harrop2*, Sean J. McKeague, MBBS, FRACP, FRCPA1*, Rory Bennett, MBChB1*, Adrian Minson, MBBS1,3, Divya V. Somasekharannair, MBBS1*, Edward Chew, MBBS, PhD, FRACP, FRCPA4, Cameron Snell, MBBS, BMedSci, DPhil, FRCPA5*, Stephen Lade, MBBS, FRCPA1,5*, Philip A. Thompson, MBBS, FRACP, FRCPA1,3, John F. Seymour, MBBS, PhD1,3, Michael J. Dickinson, MBBS, DMedSci1,3 and Mary Ann Anderson, MBBS, PhD, FRACP, FRCPA1,3,6*

1Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
2Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
3Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, VIC, Australia
4Victorian Cancer and Cytogenetics Service, St Vincent’s Hospital, Fitzroy, VIC, Australia
5Department of Pathology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
6Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia

Xiaozhi Liao1*, Tommy Li, PhD2*, Steven Xu, PhD2*, Mohamed-Eslam F Mohamed, PhD3*, Mahipal Sinnollareddy, PhD3*, Manish Gupta, PhD2*, Monica Wielgos-Bonvallet, PhD4*, Andrew J. Steele, PhD4*, Mariana Sacchi, MD2* and Yanguang Cao, PhD1*

1University of North Carolina at Chapel Hill, Chapel Hill, NC
2Genmab, Princeton, NJ
3AbbVie, North Chicago, IL
4Genmab, Plainsboro, NJ

Xia Zhao* and Zhihe Liu*

the affiliated hospital of Qingdao University, Qingdao, China

Kim Linton1*, John N. Allan, MD2, Andrew S Park, PhD, MPH3*, Anthony W Wang, PhD, MPH4*, Summer Tran, PharmD, PhD3*, Alex Mutebi, PhD5*, Zhijie Ding, PhD, MS, MBA6*, Quan Chen, DrPH, MS3* and Tycel J. Phillips, MD7

1Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
2Division of Hematology and Oncology, Weill Cornell Medicine, Long Island City, NY
3AbbVie Inc., North Chicago, IL
4AbbVie, Inc., North Chicago, IL
5Genmab US Inc, Plainsboro, NJ
6Genmab, Plainsboro, NJ
7City of Hope, Duarte, CA

Jiyeong Kim, PhD1*, Jung Hye Choi, MD, PhD2*, Young-Woong Won, MD, PhD2* and Joon Young Hur, MD, PhD2

1Department of Pre-Medicine, College of Medicine, and Biostatistics Laboratory, Medical Research Collaborating Center, Hanyang University, Seoul, Korea, Republic of (South)
2Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea, Republic of (South)

Mrunanjali Gaddam, MD1*, Samridhi Sinha, MBBS, DO2, Rabia Iqbal1*, Sujana Sanka, MD1*, Priya Thanneeru3*, Ana Colon Ramos, MD4*, Surbhi Singh, MD4*, Sobha Atluri, MD4*, Michelle Koifman, MD4*, Shahzaib Nabi, MD5* and Shreya Goyal, MD6*

1Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY
2Hematology and Oncology, The Brooklyn Hospital Center, New York, NY
3The Brooklyn Hospital center, Brooklyn
4Hematology and Oncology, The Brooklyn Hospital Center, Brooklyn, NY
5Hematology and Oncology, New York Cancer & Blood Specialists, Brooklyn, NY
6New York Cancer & Blood Specialists, Brooklyn, NY

Seisha Alana von Glasenapp, MD1, Lorena Cardozo, MD1*, Aline Nicole Paats, MD1*, Alfredo Quiroz, MD1*, Maria Elvira Enciso Arrua, MD1*, Mercedes Royg Arriola, MD1*, Rodrigo Santacruz, MD2*, Jose Zarza, MD, PhD2, Perla Noemí Britos, MD2*, Leticia Rocio Jiménez, MD3* and Luis Enrique Malpica Castillo, MD4

1Departamento de Hematología, Hospital Central Instituto de Previsión Social, Asunción, Paraguay
2Hospital de Clinicas. Universidad Nacional de Asunción, Asuncion, Paraguay
3Fundacion Tesai, Ciudad Del Este, Paraguay
4Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX

Sean E. Healton, MD, PhD1, Efrat Luttwak, MD2, Alfredo Rivas-Delgado, MD, PhD2, Alexander P. Boardman, MD2*, Philip Caron, MD2, Kevin A. David, MD2*, Zachary D. Epstein-Peterson, MD2, Lorenzo Falchi, MD2, Paola Ghione, MD2, Paul A. Hamlin, MD2, Steven Horwitz, MD2, Andrew M. Intlekofer, MD, PhD2, William T. Johnson, DO3, Anita Kumar, MD4, Alison Moskowitz, MD2, Ariela Noy, MD2, Maria Lia Palomba, MD2, Raphael E. Steiner, MD2, Robert Stuver, MD2, Pallawi Torka, MD2, Santosha A. Vardhana, MD, PhD2, Andrew D. Zelenetz, MD, PhD2, Venkatraman Seshan5*, Pallavi Galera, MBBS6, Ahmet Dogan, MD, PhD5, Gilles Salles, MD, PhD7 and Jennifer Lue, MD5*

1Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
2Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
4Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
5Memorial Sloan Kettering Cancer Center, New York, NY
6Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY

Almudena Cabero Martínez1*, Ana García Bacelar2*, Begoña Mendibil Esquisabel, MD3*, Javier Nuñez Cespedes, MD4*, Ana Jiménez Ubieto5*, Eukene Gainza Gonzalez6*, Elena Perez Ceballos7*, Beatriz De La Cruz8*, Ana Garcia Noblejas, MD, PhD9*, Paula Fernández-Caldas10*, Norma C. Gutierrez11*, Blanca Sánchez-González12*, Rocío Figueroa Mora, MD, PhD13*, Alberto Lopez Garcia, MD14, Daniel García Belmonte15*, Maria Sanchez de Castro16*, Estefania Cerezo Velasco, MD17*, Xabier Martin Martitegui18*, Hugo Daniel Luzardo Henríquez19*, Jordina Rovira20*, Luis Antonio Lopez Gomez, MD21*, Jackeline Solano22*, Ana Torres Tienza, PhD23*, Maria Stefania Infante, MD24*, Raquel Santiago Alonso25*, Raquel Del Campo26*, Dunia De Miguel Llorente27*, Alicia Roldán-Pérez28*, Emilia Pardal29*, Beatriz Gonzalez Mena, MD30*, Miguel Ángel Rodríguez Gil31*, Nazaret Domínguez Velasco32*, Albert Blanco Juan33*, Maria Alejandra Blum Dominguez34*, Javier López Marin, MD35*, María Peñarrubia-Ponce36*, Mariana Bastos-Oreiro10* and Alejandro Martín García-Sancho37*

1Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
2Hematology Department, Hospital Clínico Universitario de valladolid, Valladolid, Spain
3Hospital Universitario de Donostia, Donostia, ESP
4Hospital Universitario Marqués de Valdecilla, Santander, Spain
5Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
6Hematology Department, H.U. GALDAKAO-USANSOLO, Galdakao, Bizkaia, ESP
7Hospotal Morales Meseguer, Murcia, ESP
8Hematology Department, Hospital Universitario La Paz, Madrid, Spain
9Hematology Department, Hospital Universitario La Princesa, Madrid, Spain
10Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
11Institute of Biomedical Research of Salamanca (IBSAL), University Hospital, Salamanca, Spain
12Hematology Department, Hospital del Mar, Barcelona, Spain
13Complejo Universitario de Navarra, Navarra, Spain
14Fundacion Jimenez Diaz University Hospital, Madrid, Spain
15Hematology Department, Hospital Universitario La Zarzuela, Madrid, Spain
16Jaen Universitary Hospital, Jaén, Spain
17Hematology Department, Consorcio Sanitario de Terrassa, Terrassa, Spain
18Cruces Universitary Hospital, Bilbao, ESP
19Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
20Hematology Department, Hospital Universitari de Tarragona Joan XXIII, Institut Català d`Oncologia, Tarragona, Spain
21Hematology Department, Hospital Universitario Royo Villanova, Zaragoza, Spain
22Complejo Asistencial de Palencia, Palencia, ESP
23Complejo Asistencial de Segovia, Segovia, ESP
24HOSPITAL INFANTA LEONOR, Madrid, Madrid, ESP
25Hospital Sant Joan de Deu de Manresa, Manresa, Spain
26Hematology Department, Hospital Universitario Son Llàtzer, Palma de Mallorca, ESP
27Hospital Universitario de Guadalajara, Guadalajara, Spain, Guadalajara, Spain
28Hospital Universitario Infanta Sofía, Madrid, Spain
29Hospital Virgen Del Puerto, Plasencia, ESP
30Hospital Universitario Rio Hortega, Valladolid, ESP
31Hospital Universitario Virgen de las Nieves, Granada, Spain
32Hospital Universitario Virgen de la Macarena, Sevilla, Spain
33Hospital Francesc de Borja, Gandia, Spain
34Hospital Recoletas Salud Campo Grande, Valladolid, ESP
35Hospital Universitario Dr.Balmis, Alicante, Spain
36Hospital Clínico Universitario De Valladolid, Valladolid, ESP
37Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, University of Salamanca, Salamanca, Spain

Jinhua Liang, PhD1*, Yi-fan Wu, MD2*, Hao-Rui Shen2*, Jiazhu Wu3*, Jun-heng Liang, MD4*, Liu-Qing Zhu, MD, PhD4*, Hua Yin3*, Yue Li2*, Li Wang3*, Jianyong Li, MD5 and Xu Wei, MD, PhD3

1Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, NANJING, China
2Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
3Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
4Nanjing Geneseeq Technology Inc., Nanjing, China
5First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China

Suheil Albert Atallah-Yunes, MD1, Matthew J Rees, MD2*, Raphael Mwangi, MS3*, Robyn L Kuchler4*, Thomas M. Habermann, MD1, Matthew J. Maurer, DSc3*, James R. Cerhan, MD, PhD5, Carrie A Thompson, MD, MS1, Yucai Wang, MD, PhD1, Grzegorz S. Nowakowski, MD1, Stephen M. Ansell, MD, PhD1 and Thomas E. Witzig, MD6

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of hematology, Mayo Clinic, Rochester
3Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
4Mayo Clinic, Rochester, MN
5Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
6Division of hematology, Mayo Clinic, Rochester, MN

Prokop Vodicka1*, Katerina Benesova, MD, PhD1*, Andrea Janikova, MD, PhD2*, David Belada, MD, PhD3, Veronika Hanackova, MD4*, Heidi Mocikova, MD5*, Juraj Duras, MD, PhD6*, Katerina Steinerova, MD, PhD7*, Eva Konirova, MD1*, Tomas Prochazka, MD7*, Kamila Polgarova, MD, PhD1*, Jitka Dlouha, DiS1,8*, Petra Blahovcova, Mgr1,9* and Marek Trneny, MD, CSc10

1First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
2Department of Hematology and Oncology, Faculty of Medicine Masaryk University and University Hospital, Brno, Czech Republic
34th Department of Internal Medicine – Hematology, University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic
4Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
5Department of Internal Medicine – Hematology, Third Faculty of Medicine, Charles University and University Hospital Kralovske Vinohrady, Prague, AE
6Department of Hematology, Medical Faculty of the Ostrava University and University Hospital, Ostrava, Czech Republic
7Department of Haematology and Oncology, Faculty of Medicine, Charles University and University Hospital, Pilsen, Czech Republic
8Datacentre, Czech Lymphoma Study Group, Prague, Czech Republic
9Czech Lymphoma Study Group, Prague, Czech Republic
10First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic

Luca Ceriani, MD1*, Lisa Milan, MD2*, Maria Cristina Pirosa, MD3,4*, Alice Di Rocco, MD5*, Teresa Ruberto, MD6*, Luciano Cascione, PhD7*, Peter Johnson8*, Andrew J. Davies, MD, PhD9*, Maurizio Martelli, MD10* and Emanuele Zucca, MD11,12

1Imaging Institute of Southern Switzerland, Clinic of Nuclear Medicine and Molecular Imaging, Bellinzona, Switzerland
2Imaging Institute of Southrn Switzerland, Ente Ospedaliero Cantonale, Lugano, CHE
3Laboratory of Experimental Hematology, Institute of Oncology Research, Bellinzona, Switzerland
4Clinic of Hematology, Oncology Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Bellinzona, Switzerland
5Department of Traslational and Precision Medicine, Sapienza University of Rome, Roma, Italy
6Imaging Institute of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland
7SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
8School of Cancer Sciences, University of Southampton, Southampton, United Kingdom
9University of Southampton, School of Cancer Sciences, Southampton, United Kingdom
10Hematology, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy
11Institute of Oncology Research (IOR), Bellinzona, Switzerland
12Università della Svizzera italiana, Faculty of Biomedical Science, Lugano, Switzerland

Michal Masar, MD1*, Prokop Vodicka1*, Magdalena Klanova, MD, PhD1*, Kamila Polgarova, MD, PhD1*, Katerina Benesova, MD, PhD1*, Diana Malarikova, MD1*, Jana Salkova, MD, PhD1*, Jan Koren, MD1*, Pavel Klener, Professor, MD, PhD1* and Marek Trneny, MD, CSc2

1First Department of Medicine, First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic
2First Faculty of Medicine, Charles University and General Hospital, Prague, Czech Republic

Giulia Magno1*, Kai Rejeski, MD2,3, Giulia Rappa2,4*, Sissi Kupf2*, Sophia Stock, MD2,5,6*, Alessandra M. E. Holzem, MD2*, Julia Katharina Scholz, MD7*, Rebecca Wurm-Kuczera, MD8*, Shimrit Harlev9*, Nadine Kutsch, MD10*, Giuliano Filippini Velazquez, MD11*, Stephanie Mayer12*, Maria Landwehr, MD13*, Jamila Mammadova, MD14*, Sandeep S. Raj, MD3, Roni Shouval, MD, PhD3, Fabian Mueller, MD7, Björn Chapuy8, Ofrat Beyar-Katz, MD, PhD9*, Udo Holtick10*, Christoph Schmidt, MD, PhD11*, Hendrik Poeck12*, Gloria Iacoboni, MD13*, Pere Barba, MD13, Ning Dong, MD MS15, Veit L. Buecklein, MD2,4,5* and Marion Subklewe, MD2,4,5

1Department of Medicine III, LMU University Hospital, LMU Munich, Bolzano, Germany
2Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
3Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany
5German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
6Division of Clinical Pharmacology, University Hospital, LMU Munich, Munich, Germany
7Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
8Department of Hematology, Oncology and Cancer Immunology, Charité - University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany
9Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
10Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf; German CLL Study Group, University of Cologne, Cologne, Germany
11Department of Hematology, University Hospital Augsburg, Augsburg, Germany
12Department of Internal Medicine III (Haematology/Oncology), University Hospital Regensburg, Regensburg, Germany
13Department of Hematology, Hospital Universitari Vall d’Hebron, Barcelona, Spain
14Vanderbilt University Medical Center, Nashville, TN
15Moffitt Cancer Center, Tampa, FL

Leyre Bento De Miguel1*, Mariana Bastos-Oreiro2*, Antonio Gutierrez, MD, PhD1*, Cristina García3*, Almudena Cabero4*, Ana Jiménez Ubieto5*, Sonia González De Villambrosia6*, Alberto López7*, Santiago Browne8*, Blanca Sánchez-González9*, Paula Fernández-Caldas10*, Ana Muntañola11*, Belén Navarro12*, Ana Alarcón Tomás12*, Sandra Pérez13*, Ana Saus Carreres14*, Paola Villafuerte Gutiérrez15*, Eva Donato16*, Daniel García Belmonte17*, Jordina Rovira18*, Claudia Lozada19*, Hugo Daniel Luzardo Henríquez20*, Concepción Nicolás21*, Carlos Grande8*, Pau Abrisqueta, MD PhD3 and Alejandro Martín García-Sancho4*

1Hematology Department, Son Espases University Hospital, IdISBa, Palma, Spain
2Hematology Department, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
3Hematology Department, Hospital Universitario Vall d’Hebron, Barcelona, Spain
4Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain
5Hematology Department, Hospital 12 Octubre, Madrid, Spain
6Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
7Hematology Department, Fundación Jiménez Díaz, Madrid, Spain
8Hematology Department, Clínica Universidad de Navarra, Madrid, Spain
9Hematology Department, Hospital del Mar, Barcelona, Spain
10Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
11Hematology Department, Hospital Santa Creu i Sant Pau, Barcelona, Spain
12Hematology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
13Hematology Department., Hospital Universitario Son Espases, IdISBa., Palma, Spain
14Hematology Department, Hospital Clínico de Valencia, Valencia, Spain
15Hematology Department, Hospital Universitario Principe de Asturias, Madrid, Spain
16Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain
17Hematology Department, Hospital Universitario la Zarzuela, Madrid, Spain
18Hematology Department, Hospital Universitari de Tarragona Joan XXIII, Institut Català d`Oncologia, Tarragona, Spain
19Hematology Department, Fundación Instituto Valenciano de Oncología, Valencia, Spain
20Hematology Department, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
21Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain

Ethan A Burns, MD1, Noah Giese, MD, MEng2*, Shubham Adroja, MBBS1, Sunil Mathur1*, Chih-Hang Anthony Tang, MD, PhD3, Chih-Chi Andrew Hu, PhD4, Shilpan S. Shah, MD1*, Bin S Teh, MD, PhD5*, Amy Schefler, MD6* and Sai Ravi Pingali, MD1*

1Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Houston, TX
2Houston Methodist Hospital, Houston, TX
3Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX
4Houston Methodist Research Institute, Houston, TX
5Houston Methodist Radiation Oncology Group, Houston Methodist Hospital, Houston, TX
6Retina Consultants of Texas, Houston, TX

Jason T Romancik, MD1, Katelin Baird, BS1*, Angelo Thomas Marra, MPH2*, Amelia Langston, MD3, Pamela B. Allen, MD4, Jonathon B. Cohen, MD, MS2, Jean L. Koff, MD, MSc5, Mary Jo Lechowicz, MD3, Jeffrey M. Switchenko, PhD, MS6* and Kristie A. Blum, MD7

1Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
2Winship Cancer Institute, Emory University, Atlanta, GA
3Emory University, Winship Cancer Institute, Atlanta, GA
4Winship Cancer Institute at Emory University, Decatur, GA
5Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
6Emory University, Atlanta, GA
7Winship Cancer Institute of Emory University, Atlanta, GA

Luis Mario Villela Martinez, MD, MSc1,2*, Brady Beltran, MD3*, Alberto Villalobos Prieto, MD4, Ana Carolina Oliver, MD5, Marcela Elizabeth Zamora Matute6*, Maria Alejandra Torres Viera, MD7,8*, Seisha Von Glasenapp, MEd9, Yusaima Rodriguez-Fraga Sr., MD10*, Victoria Irigoin, MD5,11*, Sabrina Ranero Ferrari, MD11*, Maria Orlova, MD12*, German R. Stemmelin Sr., MD13*, Sofía Gabriela Rivarola, MD13*, Adrían Alejandro Ceballos López, MD14*, Jorge Montemayor, MD15, Martha Alvarado Ibarra16*, Alonso Hernandez17*, Daniela De Jesus Perez Samano18*, Álvaro Cabrera García19*, Natalia Pin Chuen Zing, MD20*, Myrna Candelaria, MD, PharmD21, Henry Idrobo, MD22*, Guilherme Fleury Perini, MD23, Rosa Oliday24*, Breno Gusmao, MD25*, Juan Daniel Garza Escobar Jr., MD26*, Marcelo Pitombeira de Lacerda, MD, PhD27,28*, Sally Paredes, MD3*, Virginia Lema Spinelli29*, Humberto Martinez-Cordero, MD30*, Rafael Martin De Jesus Pichardo Rodriguez, MD31,32*, Luis Enrique Malpica Castillo, MD33 and Jorge J. Castillo, MD34

1Hospital Fernando Ocaranza, Hermosillo, Mexico
2Centro Medico Dr. Ignacio Chavez, Hermosillo, Sonora, MEX
3Hospital Edgardo Rebagliati Martins, Lima, Peru
4Centro Medico ABC, Ciudad de Mexico, Mexico
5Bone marrow transplant unit, British Hospital, Montevideo, Uruguay
6Banco de Sangre, Hospital Metropolitano, Quito, ECU
7Unidad Linfomas, Instituto Hematología y Oncología Universidad Central Venezuela, Caracas, Venezuela (Bolivarian Republic of)
8Clinica Santa Sofia, Caracas, Venezuela (Bolivarian Republic of)
9Departamento de Hematologia, Instituo de Previsión Social, Asunción, Paraguay
10Hospital Clínico Quirúrgico “Hermanos Ameijeiras”, La Habana, Cuba
11Hospital de Clinicas, Montevideo, Uruguay
12Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
13Hospital Británico, Buenos Aires, Argentina
14Laboratorios Biomedicos de Merida, Merida, Mexico
15Hospital Universitario, Monterrey, MEX
16Hospital Angeles Lomas, Mexico, Mexico
17Hospital General de Mexico Eduardo Liceaga, Ciudad de Mexico, Mexico
18Hospital General de México, Mexico city, Mexico
192. Hematology Department, Regional Hospital of High Specialty of Ixtapaluca, Estado de México, Mexico., Ixtapaluca, Estado De México, Mexico, MEX
20Beneficência Portuguesa de São Paulo, São Paulo, AC, Brazil
21Clinical Research, Instituto Nacional de Cancerología, Mexico, Mexico
22Universidad del Valle del Cauca, Cali, COL
23Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil
24Hospital Militar Dr. Luis Diaz Soto, Havanna, Cuba
25Onco-Hematologia, Beneficência Portuguesa, São Paulo, Brazil
26Centro Medico Dr. Ignacio Chavez ISSSTESONA, Hermosillo Sonora, Mexico
27Universidade da Região de Joinville (Univille), Joinville, Santa Catarina, Brazil
28UNIFESP, SAO PAULO, Brazil
29Cátedra De Hematología Hospital De Clinicas, Montevideo, Uruguay
30SUBDIRECCIÓN GENERAL DE ATENCIÓN MEDICA Y DOCENCIA, INSTITUTO NACIONAL DE CANCEROLOGIA, Nariño, Colombia
31Hospital de Apoyo II-2 de Sullana, Piura, Peru
32Escuela de Medicina, Universidad César Vallejo, Piura, Peru
33Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
34Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA

*signifies non-member of ASH